Cargando…

Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile

Antibiotic disruption of the intestinal microbiota may cause susceptibility to pathogens that is resolved by progressive bacterial outgrowth and colonization. Succession is central to ecological theory but not widely documented in studies of the vertebrate microbiome. Here, we study succession in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterfreund, Gregory L., Vandivier, Lee E., Sinha, Rohini, Marozsan, Andre J., Olson, William C., Zhu, Jun, Bushman, Frederic D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468616/
https://www.ncbi.nlm.nih.gov/pubmed/23071679
http://dx.doi.org/10.1371/journal.pone.0046966
_version_ 1782245972419543040
author Peterfreund, Gregory L.
Vandivier, Lee E.
Sinha, Rohini
Marozsan, Andre J.
Olson, William C.
Zhu, Jun
Bushman, Frederic D.
author_facet Peterfreund, Gregory L.
Vandivier, Lee E.
Sinha, Rohini
Marozsan, Andre J.
Olson, William C.
Zhu, Jun
Bushman, Frederic D.
author_sort Peterfreund, Gregory L.
collection PubMed
description Antibiotic disruption of the intestinal microbiota may cause susceptibility to pathogens that is resolved by progressive bacterial outgrowth and colonization. Succession is central to ecological theory but not widely documented in studies of the vertebrate microbiome. Here, we study succession in the hamster gut after treatment with antibiotics and exposure to Clostridium difficile. C. difficile infection is typically lethal in hamsters, but protection can be conferred with neutralizing antibodies against the A and B toxins. We compare treatment with neutralizing monoclonal antibodies (mAb) to treatment with vancomycin, which prolongs the lives of animals but ultimately fails to protect them from death. We carried out longitudinal deep sequencing analysis and found distinctive waves of succession associated with each form of treatment. Clindamycin sensitization prior to infection was associated with the temporary suppression of the previously dominant Bacteroidales and the fungus Saccinobaculus in favor of Proteobacteria. In mAb-treated animals, C. difficile proliferated before joining Proteobacteria in giving way to re-expanding Bacteroidales and the fungus Wickerhamomyces. However, the Bacteroidales lineages returning by day 7 were different from those that were present initially, and they persisted for the duration of the experiment. Animals treated with vancomycin showed a different set of late-stage lineages that were dominated by Proteobacteria as well as increased disparity between the tissue-associated and luminal cecal communities. The control animals showed no change in their gut microbiota. These data thus suggest different patterns of ecological succession following antibiotic treatment and C. difficile infection.
format Online
Article
Text
id pubmed-3468616
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34686162012-10-15 Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile Peterfreund, Gregory L. Vandivier, Lee E. Sinha, Rohini Marozsan, Andre J. Olson, William C. Zhu, Jun Bushman, Frederic D. PLoS One Research Article Antibiotic disruption of the intestinal microbiota may cause susceptibility to pathogens that is resolved by progressive bacterial outgrowth and colonization. Succession is central to ecological theory but not widely documented in studies of the vertebrate microbiome. Here, we study succession in the hamster gut after treatment with antibiotics and exposure to Clostridium difficile. C. difficile infection is typically lethal in hamsters, but protection can be conferred with neutralizing antibodies against the A and B toxins. We compare treatment with neutralizing monoclonal antibodies (mAb) to treatment with vancomycin, which prolongs the lives of animals but ultimately fails to protect them from death. We carried out longitudinal deep sequencing analysis and found distinctive waves of succession associated with each form of treatment. Clindamycin sensitization prior to infection was associated with the temporary suppression of the previously dominant Bacteroidales and the fungus Saccinobaculus in favor of Proteobacteria. In mAb-treated animals, C. difficile proliferated before joining Proteobacteria in giving way to re-expanding Bacteroidales and the fungus Wickerhamomyces. However, the Bacteroidales lineages returning by day 7 were different from those that were present initially, and they persisted for the duration of the experiment. Animals treated with vancomycin showed a different set of late-stage lineages that were dominated by Proteobacteria as well as increased disparity between the tissue-associated and luminal cecal communities. The control animals showed no change in their gut microbiota. These data thus suggest different patterns of ecological succession following antibiotic treatment and C. difficile infection. Public Library of Science 2012-10-10 /pmc/articles/PMC3468616/ /pubmed/23071679 http://dx.doi.org/10.1371/journal.pone.0046966 Text en © 2012 Peterfreund et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Peterfreund, Gregory L.
Vandivier, Lee E.
Sinha, Rohini
Marozsan, Andre J.
Olson, William C.
Zhu, Jun
Bushman, Frederic D.
Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
title Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
title_full Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
title_fullStr Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
title_full_unstemmed Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
title_short Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
title_sort succession in the gut microbiome following antibiotic and antibody therapies for clostridium difficile
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468616/
https://www.ncbi.nlm.nih.gov/pubmed/23071679
http://dx.doi.org/10.1371/journal.pone.0046966
work_keys_str_mv AT peterfreundgregoryl successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile
AT vandivierleee successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile
AT sinharohini successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile
AT marozsanandrej successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile
AT olsonwilliamc successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile
AT zhujun successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile
AT bushmanfredericd successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile